Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Identification and Characterization of a Cell Wall Hydrolase for Sporangiospore Maturation in Actinoplanes missouriensis.

Mitsuyama K, Tezuka T, Ohnishi Y.

J Bacteriol. 2019 Nov 20;201(24). pii: e00519-19. doi: 10.1128/JB.00519-19. Print 2019 Dec 15.

PMID:
31570527
2.

Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study.

Naganuma M, Sugimoto S, Fukuda T, Mitsuyama K, Kobayashi T, Yoshimura N, Ohi H, Tanaka S, Andoh A, Ohmiya N, Saigusa K, Yamamoto T, Morohoshi Y, Ichikawa H, Matsuoka K, Hisamatsu T, Watanabe K, Mizuno S, Abe T, Suzuki Y, Kanai T; INDIGO Study Group.

J Gastroenterol. 2019 Sep 16. doi: 10.1007/s00535-019-01625-2. [Epub ahead of print]

PMID:
31529220
3.

Questionnaire Survey from the 1st Kurume University Inflammatory Bowel Disease Center Educational Lecture.

Yamasaki H, Kinugasa T, Iwasaki S, Yoshioka S, Mizuochi T, Ishibashi M, Nagatsuka K, Yamauchi R, Ishibashi N, Araki T, Mori A, Akagi Y, Mitsuyama K, Torimura T.

Kurume Med J. 2019 Sep 25;65(3):109-112. doi: 10.2739/kurumemedj.MS653004. Epub 2019 Aug 9.

4.

Early weaning increases anxiety via brain-derived neurotrophic factor signaling in the mouse prefrontal cortex.

Kikusui T, Kanbara N, Ozaki M, Hirayama N, Ida K, Tokita M, Tanabe N, Mitsuyama K, Abe H, Yoshida M, Nagasawa M, Mogi K.

Sci Rep. 2019 Mar 8;9(1):3991. doi: 10.1038/s41598-019-40530-9.

5.

Prediction of colorectal tumor grade and invasion depth through narrow-band imaging scoring.

Maeyama Y, Mitsuyama K, Noda T, Nagata S, Nagata T, Yoshioka S, Yoshida H, Mukasa M, Sumie H, Kawano H, Akiba J, Araki Y, Kakuma T, Tsuruta O, Torimura T.

World J Gastroenterol. 2018 Nov 14;24(42):4809-4820. doi: 10.3748/wjg.v24.i42.4809.

6.

The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review.

Yamauchi R, Araki T, Mitsuyama K, Tokito T, Ishii H, Yoshioka S, Kuwaki K, Mori A, Yoshimura T, Tsuruta O, Torimura T.

BMC Gastroenterol. 2018 Aug 31;18(1):135. doi: 10.1186/s12876-018-0864-1. Review.

7.

Effect of a concomitant elemental diet with maintenance anti-tumor necrosis factor-α antibody therapy in patients with Crohn's disease: A multicenter, prospective cohort study.

Hirai F, Ishida T, Takeshima F, Yamamoto S, Yoshikawa I, Ashizuka S, Inatsu H, Mitsuyama K, Sou S, Iwakiri R, Nozaki R, Ohi H, Esaki M, Iida M, Matsui T; Additional Power of Elemental Diet on Maintenance Biologics Therapy in Crohn's Disease (ADORE) Study Group.

J Gastroenterol Hepatol. 2019 Jan;34(1):132-139. doi: 10.1111/jgh.14361. Epub 2018 Jul 16.

PMID:
29935082
8.

Endoscopic analysis of colorectal serrated lesions with cancer.

Nagata S, Mitsuyama K, Kawano H, Noda T, Maeyama Y, Mukasa M, Takedatsu H, Yoshioka S, Kuwaki K, Akiba J, Tsuruta O, Torimura T.

Oncol Lett. 2018 Jun;15(6):8655-8662. doi: 10.3892/ol.2018.8386. Epub 2018 Mar 29.

9.

Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter-3 in immunoglobulin G4-related autoimmune hepatitis.

Araki T, Arinaga-Hino T, Koga H, Akiba J, Ide T, Okabe Y, Kuwahara R, Amano K, Yasumoto M, Kawaguchi T, Sano T, Kondou R, Kurata S, Mitsuyama K, Torimura T.

Hepatol Res. 2018 Oct;48(11):937-944. doi: 10.1111/hepr.13188. Epub 2018 Jun 4.

PMID:
29737040
10.

Diagnostic and clinical role of serum proteinase 3 antineutrophil cytoplasmic antibodies in inflammatory bowel disease.

Takedatsu H, Mitsuyama K, Fukunaga S, Yoshioka S, Yamauchi R, Mori A, Yamasaki H, Kuwaki K, Sakisaka H, Sakisaka S, Torimura T.

J Gastroenterol Hepatol. 2018 Mar 7. doi: 10.1111/jgh.14140. [Epub ahead of print]

PMID:
29514409
11.

Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.

Naganuma M, Sugimoto S, Mitsuyama K, Kobayashi T, Yoshimura N, Ohi H, Tanaka S, Andoh A, Ohmiya N, Saigusa K, Yamamoto T, Morohoshi Y, Ichikawa H, Matsuoka K, Hisamatsu T, Watanabe K, Mizuno S, Suda W, Hattori M, Fukuda S, Hirayama A, Abe T, Watanabe M, Hibi T, Suzuki Y, Kanai T; INDIGO Study Group.

Gastroenterology. 2018 Mar;154(4):935-947. doi: 10.1053/j.gastro.2017.11.024. Epub 2017 Nov 22.

PMID:
29174928
12.

Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization.

Fukunaga S, Kuwaki K, Mitsuyama K, Takedatsu H, Yoshioka S, Yamasaki H, Yamauchi R, Mori A, Kakuma T, Tsuruta O, Torimura T.

Int J Mol Med. 2018 Jan;41(1):107-118. doi: 10.3892/ijmm.2017.3244. Epub 2017 Nov 7.

13.

Stereomicroscopic features of colitis-associated tumors in mice: Evaluation of pit pattern.

Yamauchi R, Kominato K, Mitsuyama K, Takedatsu H, Yoshioka S, Kuwaki K, Yamasaki H, Fukunaga S, Mori A, Akiba J, Tsuruta O, Torimura T.

Oncol Lett. 2017 Sep;14(3):3675-3682. doi: 10.3892/ol.2017.6645. Epub 2017 Jul 21.

14.

Study to determine guidelines for pediatric colonoscopy.

Yoshioka S, Takedatsu H, Fukunaga S, Kuwaki K, Yamasaki H, Yamauchi R, Mori A, Kawano H, Yanagi T, Mizuochi T, Ushijima K, Mitsuyama K, Tsuruta O, Torimura T.

World J Gastroenterol. 2017 Aug 21;23(31):5773-5779. doi: 10.3748/wjg.v23.i31.5773.

15.

A Rare Case of Ulcerative Colitis with Neurofibromatosis Type 1.

Fukunaga S, Takedatsu H, Mitsuyama K, Torimura T.

Kurume Med J. 2018 Feb 26;64(1.2):25-27. doi: 10.2739/kurumemedj.MS00014. Epub 2017 Jul 3.

16.

Duodenal Metastases from Lung Carcinoma.

Mori A, Yamasaki H, Takedatsu H, Mitsuyama K.

Intern Med. 2017;56(5):573-574. doi: 10.2169/internalmedicine.56.7247. Epub 2017 Mar 1. No abstract available.

17.

An unusual cause of colonic stricture with polyps.

Fukunaga S, Takedatsu H, Muta H, Mitsuyama K, Torimura T.

Gut. 2017 Aug;66(8):1495. doi: 10.1136/gutjnl-2016-312737. Epub 2016 Oct 18. No abstract available.

PMID:
27797939
18.

Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer.

Watanabe T, Ajioka Y, Mitsuyama K, Watanabe K, Hanai H, Nakase H, Kunisaki R, Matsuda K, Iwakiri R, Hida N, Tanaka S, Takeuchi Y, Ohtsuka K, Murakami K, Kobayashi K, Iwao Y, Nagahori M, Iizuka B, Hata K, Igarashi M, Hirata I, Kudo SE, Matsumoto T, Ueno F, Watanabe G, Ikegami M, Ito Y, Oba K, Inoue E, Tomotsugu N, Takebayashi T, Sugihara K, Suzuki Y, Watanabe M, Hibi T.

Gastroenterology. 2016 Dec;151(6):1122-1130. doi: 10.1053/j.gastro.2016.08.002. Epub 2016 Aug 12.

19.

Increased levels of circulating adrenomedullin following treatment with TU‑100 in patients with Crohn's disease.

Kominato K, Yamasaki H, Mitsuyama K, Takedatsu H, Yoshioka S, Kuwaki K, Kobayashi T, Yamauchi R, Fukunaga S, Tsuruta O, Torimura T.

Mol Med Rep. 2016 Sep;14(3):2264-8. doi: 10.3892/mmr.2016.5488. Epub 2016 Jul 8.

PMID:
27432470
20.

Novel exonic mutation inducing aberrant splicing in the IL10RA gene and resulting in infantile-onset inflammatory bowel disease: a case report.

Yanagi T, Mizuochi T, Takaki Y, Eda K, Mitsuyama K, Ishimura M, Takada H, Shouval DS, Griffith AE, Snapper SB, Yamashita Y, Yamamoto K.

BMC Gastroenterol. 2016 Jan 28;16:10. doi: 10.1186/s12876-016-0424-5.

21.

Antibody markers in the diagnosis of inflammatory bowel disease.

Mitsuyama K, Niwa M, Takedatsu H, Yamasaki H, Kuwaki K, Yoshioka S, Yamauchi R, Fukunaga S, Torimura T.

World J Gastroenterol. 2016 Jan 21;22(3):1304-10. doi: 10.3748/wjg.v22.i3.1304. Review.

22.

A longitudinal study of FDG-PET in Crohn disease patients receiving granulocyte/monocyte apheresis therapy.

Kuwaki K, Mitsuyama K, Kaida H, Takedatsu H, Yoshioka S, Yamasaki H, Yamauchi R, Fukunaga S, Abe T, Tsuruta O, Torimura T.

Cytotherapy. 2016 Feb;18(2):291-9. doi: 10.1016/j.jcyt.2015.10.010. Epub 2015 Dec 14.

PMID:
26700210
23.

Advanced endoscopic features of ulcerative colitis-associated neoplasias: Quantification of autofluorescence imaging.

Yoshioka S, Mitsuyama K, Takedatsu H, Kuwaki K, Yamauchi R, Yamasaki H, Fukunaga S, Akiba J, Kinugasa T, Akagi Y, Tsuruta O, Torimura T.

Int J Oncol. 2016 Feb;48(2):551-8. doi: 10.3892/ijo.2015.3284. Epub 2015 Dec 9.

PMID:
26676295
24.

An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease.

Yoshimura N, Yokoyama Y, Matsuoka K, Takahashi H, Iwakiri R, Yamamoto T, Nakagawa T, Fukuchi T, Motoya S, Kunisaki R, Kato S, Hirai F, Ishiguro Y, Tanida S, Hiraoka S, Mitsuyama K, Ishihara S, Tanaka S, Otaka M, Osada T, Kagaya T, Suzuki Y, Nakase H, Hanai H, Watanabe K, Kashiwagi N, Hibi T.

BMC Gastroenterol. 2015 Nov 19;15:163. doi: 10.1186/s12876-015-0390-3.

25.

Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease.

Takedatsu H, Mitsuyama K, Torimura T.

World J Gastroenterol. 2015 Oct 28;21(40):11343-52. doi: 10.3748/wjg.v21.i40.11343. Review.

26.

Ulcerative colitis in a patient with non-small-cell lung cancer receiving bevacizumab.

Tanaka M, Ishii H, Azuma K, Saisho C, Matsuo N, Imamura Y, Tokito T, Kinoshita T, Yamada K, Takedatsu H, Mitsuyama K, Hoshino T.

Invest New Drugs. 2015 Oct;33(5):1133-5. doi: 10.1007/s10637-015-0279-6. Epub 2015 Aug 18.

PMID:
26280212
27.

Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.

Inoue H, Emori K, Toyonaga A, Oho K, Kumamoto M, Haruta T, Mitsuyama K, Tsuruta O, Sata M.

Kurume Med J. 2014;61(1-2):1-8. doi: 10.2739/kurumemedj.MS63014. Epub 2014 Nov 25.

28.

Adalimumab for the treatment of Japanese patients with intestinal Behçet's disease.

Tanida S, Inoue N, Kobayashi K, Naganuma M, Hirai F, Iizuka B, Watanabe K, Mitsuyama K, Inoue T, Ishigatsubo Y, Suzuki Y, Nagahori M, Motoya S, Nakamura S, Arora V, Robinson AM, Thakkar RB, Hibi T.

Clin Gastroenterol Hepatol. 2015 May;13(5):940-8.e3. doi: 10.1016/j.cgh.2014.08.042. Epub 2014 Sep 19.

29.

Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.

Nagayama K, Takedatsu H, Mitsuyama K, Yamasaki H, Kuwaki K, Yoshioka S, Kobayashi T, Yamauchi R, Kakuma T, Sata M.

Ther Apher Dial. 2014 Jun;18(3):244-51. doi: 10.1111/1744-9987.12211.

PMID:
24965290
30.

Balloon-occluded retrograde transvenous obliteration versus endoscopic injection sclerotherapy for isolated gastric varices: a comparative study.

Emori K, Toyonaga A, Oho K, Kumamoto M, Haruta T, Inoue H, Morita Y, Mitsuyama K, Tsuruta O, Sata M.

Kurume Med J. 2014;60(3-4):105-13. Epub 2014 May 26.

31.

Successful treatment of rectal ulcers in a patient with systemic lupus erythematosus using corticosteroids and tacrolimus.

Kaieda S, Kobayashi T, Moroki M, Honda S, Yuge K, Kawano H, Mitsuyama K, Sata M, Ida H, Hoshino T, Fukuda T.

Mod Rheumatol. 2014 Mar;24(2):357-60. doi: 10.3109/14397595.2013.852846.

PMID:
24593214
32.

Possible diagnostic role of antibodies to Crohn's disease peptide (ACP): results of a multicenter study in a Japanese cohort.

Mitsuyama K, Niwa M, Masuda J, Yamasaki H, Kuwaki K, Takedatsu H, Kobayashi T, Kinjo F, Kishimoto K, Matsui T, Hirai F, Makiyama K, Ohba K, Abe H, Tsubouchi H, Fujita H, Maekawa R, Yoshida H, Sata M; Kyushu ACP Study Group.

J Gastroenterol. 2014 Apr;49(4):683-91. doi: 10.1007/s00535-013-0916-9. Epub 2013 Dec 3.

PMID:
24297319
33.

Effects of the modulation of microbiota on the gastrointestinal immune system and bowel function.

Kanauchi O, Andoh A, Mitsuyama K.

J Agric Food Chem. 2013 Oct 23;61(42):9977-83. doi: 10.1021/jf402441f. Epub 2013 Oct 15. Review.

PMID:
24070265
34.

Probiotics promote rapid-turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis.

Koga H, Tamiya Y, Mitsuyama K, Ishibashi M, Matsumoto S, Imaoka A, Hara T, Nakano M, Ooeda K, Umezaki Y, Sata M.

Hepatol Int. 2013 Jun;7(2):767-74. doi: 10.1007/s12072-012-9408-x. Epub 2012 Nov 21.

PMID:
26201812
35.

Microarray analyses of peripheral whole blood cells from ulcerative colitis patients: effects of leukocytapheresis.

Kobayashi T, Mitsuyama K, Yamasaki H, Masuda J, Takedatsu H, Kuwaki K, Yoshioka S, Nagayama K, Sata M.

Int J Mol Med. 2013 Apr;31(4):789-96. doi: 10.3892/ijmm.2013.1270. Epub 2013 Feb 6.

PMID:
23403617
36.

The new prophylactic strategy for colon cancer in inflammatory bowel disease by modulating microbiota.

Kanauchi O, Mitsuyama K, Andoh A.

Scand J Gastroenterol. 2013 Apr;48(4):387-400. doi: 10.3109/00365521.2012.741617. Epub 2012 Dec 19. Review.

PMID:
23249220
37.

[Efficacy of probiotics in inflammatory bowel disease].

Mitsuyama K.

Nihon Rinsho. 2012 Feb;70 Suppl 1:358-64. Japanese. No abstract available.

PMID:
23126118
38.

[Guidelines for treatment of Crohn's disease].

Mitsuyama K.

Nihon Rinsho. 2012 Feb;70 Suppl 1:305-9. Japanese. No abstract available.

PMID:
23126107
39.

Endoscopic discrimination of sessile serrated adenomas from other serrated lesions.

Hasegawa S, Mitsuyama K, Kawano H, Arita K, Maeyama Y, Akagi Y, Watanabe Y, Okabe Y, Tsuruta O, Sata M.

Oncol Lett. 2011 Sep 1;2(5):785-789. Epub 2011 Jul 5.

40.

N-butyl-2-cyanoacrylate (histoacryl) glue in the right atrium after endoscopic injection for a ruptured duodenal varix: complication of histoacryl injection.

Miyakoda K, Takedatsu H, Emori K, Inoue H, Toyonaga A, Mitsuyama K, Tsuruta O, Sata M.

Dig Endosc. 2012 May;24(3):192. doi: 10.1111/j.1443-1661.2011.01185.x. No abstract available.

PMID:
22507099
41.

A new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel disease.

Takedatsu H, Mitsuyama K, Mochizuki S, Kobayashi T, Sakurai K, Takeda H, Fujiyama Y, Koyama Y, Nishihira J, Sata M.

Mol Ther. 2012 Jun;20(6):1234-41. doi: 10.1038/mt.2012.24. Epub 2012 Feb 14.

42.

Development of intrahepatic cholangiocarcinoma after a 14-year follow-up of a patient with primary sclerosing cholangitis and ulcerative colitis.

Kawaguchi T, Kaji R, Horiuchi H, Shirono T, Ishida Y, Okabe Y, Itou M, Mitsuyama K, Akiba J, Nakashima O, Yano H, Kage M, Harada M, Sakisaka S, Sata M.

Hepatol Res. 2011 Dec;41(12):1253-9. doi: 10.1111/j.1872-034X.2011.00875.x.

PMID:
22118304
43.

Serum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patients.

Kaji R, Takedatsu H, Okabe Y, Ishida Y, Sugiyama G, Yonemoto K, Mitsuyama K, Tsuruta O, Sata M.

J Gastroenterol Hepatol. 2012 Feb;27(2):268-72. doi: 10.1111/j.1440-1746.2011.06933.x.

PMID:
21929654
44.

Isolation and characterization of a novel short peptide associated with Crohn's disease.

Mitsuyama K, Niwa M, Masuda J, Kuwaki K, Yamasaki H, Takedatsu H, Kobayashi T, Sata M.

Clin Exp Immunol. 2011 Oct;166(1):72-9. doi: 10.1111/j.1365-2249.2011.04444.x. Epub 2011 Jul 28.

45.

Prebiotic treatment reduced preneoplastic lesions through the downregulation of toll like receptor 4 in a chemo-induced carcinogenic model.

Fukuda M, Komiyama Y, Mitsuyama K, Andoh A, Aoyama T, Matsumoto Y, Kanauchi O.

J Clin Biochem Nutr. 2011 Jul;49(1):57-61. doi: 10.3164/jcbn.10-114. Epub 2011 May 14.

46.

Quantitative analysis of colorectal mucosal lesions by autofluorescence endoscopy: discrimination of carcinomas from other lesions.

Arita K, Mitsuyama K, Kawano H, Hasegawa S, Maeyama Y, Masuda J, Akagi Y, Watanabe Y, Okabe Y, Tsuruta O, Sata M.

Oncol Rep. 2011 Jul;26(1):43-8. doi: 10.3892/or.2011.1287. Epub 2011 Apr 28.

PMID:
21573495
47.

A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitis.

Ashida T, Kohgo Y, Munakata A, Noguchi M, Iizuka B, Endo Y, Hanai H, Yoshikawa T, Matsumoto T, Aoyama N, Matsui T, Mitsuyama K, Hibi T.

Transfus Apher Sci. 2011 Apr;44(2):113-7. doi: 10.1016/j.transci.2011.01.001.

PMID:
21402309
48.

Prebiotic treatment in experimental colitis reduces the risk of colitic cancer.

Komiyama Y, Mitsuyama K, Masuda J, Yamasaki H, Takedatsu H, Andoh A, Tsuruta O, Fukuda M, Kanauchi O.

J Gastroenterol Hepatol. 2011 Aug;26(8):1298-308. doi: 10.1111/j.1440-1746.2011.06690.x.

PMID:
21303406
49.

Clinical trial: Effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III parallel-dosing study.

Hiwatashi N, Suzuki Y, Mitsuyama K, Munakata A, Hibi T.

J Gastroenterol. 2011 Jan;46(1):46-56. doi: 10.1007/s00535-010-0308-3. Epub 2010 Sep 29.

PMID:
20878425
50.

New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system.

Komiyama Y, Andoh A, Fujiwara D, Ohmae H, Araki Y, Fujiyama Y, Mitsuyama K, Kanauchi O.

Scand J Gastroenterol. 2011 Jan;46(1):40-52. doi: 10.3109/00365521.2010.513062. Epub 2010 Aug 24.

PMID:
20735154

Supplemental Content

Loading ...
Support Center